New asthma inhaler propellant tested for Long-Term safety

NCT ID NCT06261957

Completed Disease control Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

Summary

This study tested whether a new propellant (HFA-152a) in asthma rescue inhalers is as safe as the current standard propellant (HFA-134a). 477 adults with stable asthma used inhalers containing one of the two propellants for an extended period. Researchers monitored participants for side effects and changes in blood tests, vital signs, and asthma control to compare the safety profiles.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

GSK Investigational Site

North Hollywood, California, 91606-3287, United States
GSK Investigational Site

San Mateo, California, 94403, United States
GSK Investigational Site

Aventura, Florida, 33180, United States
GSK Investigational Site

Clearwater, Florida, 33756, United States
GSK Investigational Site

DeLand, Florida, 32720, United States
GSK Investigational Site

Miami, Florida, 33144, United States
GSK Investigational Site

Miami, Florida, 33155, United States
GSK Investigational Site

Miami, Florida, 33173, United States
GSK Investigational Site

Naples, Florida, 34102, United States
GSK Investigational Site

Plantation, Florida, 33317, United States
GSK Investigational Site

Winter Park, Florida, 32789, United States
GSK Investigational Site

Rincon, Georgia, 31326, United States
GSK Investigational Site

Stonecrest, Georgia, 30038, United States
GSK Investigational Site

Louisville, Kentucky, 40217, United States
GSK Investigational Site

Owensboro, Kentucky, 42301, United States
GSK Investigational Site

Fall River, Massachusetts, 02723, United States
GSK Investigational Site

Minneapolis, Minnesota, 55402, United States
GSK Investigational Site

Minneota, Minnesota, 56001, United States
GSK Investigational Site

Olive Branch, Mississippi, 38654, United States
GSK Investigational Site

Columbia, Missouri, 65203, United States
GSK Investigational Site

Henderson, Nevada, 89052, United States
GSK Investigational Site

Jersey City, New Jersey, 07306, United States
GSK Investigational Site

Riverdale, New Jersey, 07457, United States
GSK Investigational Site

Brooklyn, New York, 11220, United States
GSK Investigational Site

Asheville, North Carolina, 28803, United States
GSK Investigational Site

Winston-Salem, North Carolina, 27104, United States
GSK Investigational Site

Cincinnati, Ohio, 45231, United States
GSK Investigational Site

Dublin, Ohio, 43016, United States
GSK Investigational Site

Medford, Oregon, 97504, United States
GSK Investigational Site

Philadelphia, Pennsylvania, 19107, United States
GSK Investigational Site

Pittsburgh, Pennsylvania, 15241, United States
GSK Investigational Site

Pottstown, Pennsylvania, 19464, United States
GSK Investigational Site

Rock Hill, South Carolina, 29732, United States
GSK Investigational Site

Spartanburg, South Carolina, 29303, United States
GSK Investigational Site

Union, South Carolina, 29379, United States
GSK Investigational Site

Sugar Land, Texas, 77479, United States
GSK Investigational Site

Tomball, Texas, 77375, United States
GSK Investigational Site

Buenos Aires, C1425AZE, Argentina
GSK Investigational Site

Buenos Aires, C1425BEN, Argentina
GSK Investigational Site

Buenos Aires, C1426ABP, Argentina
GSK Investigational Site

La Plata, 1900, Argentina
GSK Investigational Site

Mendoza, M5500CCG, Argentina
GSK Investigational Site

Botany, New South Wales, 2019, Australia
GSK Investigational Site

Coffs Harbour, New South Wales, 2450, Australia
GSK Investigational Site

Kanwal, New South Wales, 2259, Australia
GSK Investigational Site

Spearwood, Western Australia, 6163, Australia
GSK Investigational Site

Ajax, Ontario, L1S 2J5, Canada
GSK Investigational Site

Brampton, Ontario, L6T 0G1, Canada
GSK Investigational Site

Ottawa, Ontario, K1H 1E4, Canada
GSK Investigational Site

Toronto, Ontario, M9V 4B4, Canada
GSK Investigational Site

Windsor, Ontario, N8X 2G1, Canada
GSK Investigational Site

Québec, Quebec, G1V 4W2, Canada
GSK Investigational Site

Québec, Quebec, G1W 4R4, Canada
GSK Investigational Site

Amiens, 80054, France
GSK Investigational Site

Argenteuil, 95100, France
GSK Investigational Site

Créteil, 94010, France
GSK Investigational Site

Poitiers, 86021, France
GSK Investigational Site

Pontoise, 95303, France
GSK Investigational Site

Strasbourg, 67091, France
GSK Investigational Site

Athens, 15669, Greece
GSK Investigational Site

Larissa, 41110, Greece
GSK Investigational Site

Thessaloniki, 57010, Greece
GSK Investigational Site

Cagliari, 09042, Italy
GSK Investigational Site

Florence, 50134, Italy
GSK Investigational Site

Foggia, 71100, Italy
GSK Investigational Site

Milan, 20162, Italy
GSK Investigational Site

Napoli, 80131, Italy
GSK Investigational Site

Padua, 35128, Italy
GSK Investigational Site

Roma, Italy
GSK Investigational Site

Torino, 10128, Italy
GSK Investigational Site

Tradate VA, 21100, Italy
GSK Investigational Site

Verona, 37134, Italy
GSK Investigational Site

Panama City, 7002, Panama
GSK Investigational Site

Panama City, 7099, Panama
GSK Investigational Site

Panama City, Panama
GSK Investigational Site

Iloilo City, 5000, Philippines
GSK Investigational Site

Bialystok, 15-010, Poland
GSK Investigational Site

Bielsko-Biala, 43-300, Poland
GSK Investigational Site

Chorzów, 41-500, Poland
GSK Investigational Site

Elblag, 82-300, Poland
GSK Investigational Site

Katowice, 40-600, Poland
GSK Investigational Site

Ostrowiec Świętokrzyski, 27-400, Poland
GSK Investigational Site

Płock, 09-407, Poland
GSK Investigational Site

Tarnów, 33-100, Poland
GSK Investigational Site

Barcelona, 08017, Spain
GSK Investigational Site

Barcelona, 08540, Spain
GSK Investigational Site

Benalmádena, 29631, Spain
GSK Investigational Site

Madrid, 28031, Spain
GSK Investigational Site

Madrid, 28040, Spain
GSK Investigational Site

Madrid, 28041, Spain
GSK Investigational Site

Marbella, 29603, Spain
GSK Investigational Site

Pozuelo de AlarcOn Madr, 28223, Spain
GSK Investigational Site

Pathum Thani, 12120, Thailand
GSK Investigational Site

Bebington, CH63 9JP, United Kingdom
GSK Investigational Site

Cambridgeshire, CB7 5JD, United Kingdom
GSK Investigational Site

Corby, NN17 2UR, United Kingdom
GSK Investigational Site

Greater Manchester, OL6 6HD, United Kingdom
GSK Investigational Site

Guisborough, TS14 7DJ, United Kingdom
GSK Investigational Site

Hounslow, TW3 3EL, United Kingdom
GSK Investigational Site

Rhyl, LL18 4HZ, United Kingdom
GSK Investigational Site

Uttoxeter, ST14 5JX, United Kingdom

Conditions

Explore the condition pages connected to this study.

ASTHMA